Clinical Trial Detail

NCT ID NCT00074490
Title Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements no
Sponsors National Cancer Institute (NCI)
Indications

hematologic cancer

myeloproliferative neoplasm

Therapies

Cyclophosphamide

Cyclosporine

Rituximab

Doxorubicin

Etoposide

Filgrastim

Vincristine

Fludarabine

Age Groups: adult child

No variant requirements are available.